Elisa Tirtei
-
- Neuroblastoma Research and Treatments 6
-
- Cancer Genomics and Diagnostics 3
-
- Vascular Tumors and Angiosarcomas 2
-
- Sarcoma Diagnosis and Treatment 12
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Bone Tumor Diagnosis and Treatments 5
-
- Genetic Syndromes and Imprinting 2
-
- Acute Myeloid Leukemia Research 2
- Co-authors
- Franca FagioliSebastian Dorin AsafteiMatteo CeredaAnna PaioliMarilena CesariM. RoccaNicoletta BertorelloEleonora Biasin
- Cited by
- NeurologyCancer ResearchOncology
- Journals
- Journal of Clinical Oncology (1 paper)PLoS ONE (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ItalyDenmarkUnited Kingdom
In The Last Decade
Elisa Tirtei
20 papers receiving 190 citations
Peers
Comparison fields: 5 of 51
- Neurology 42
- Cancer Research 36
- Oncology 57
- Pulmonary and Respiratory Medicine 64
- Pediatrics, Perinatology and Child Health 30
Countries citing papers authored by Elisa Tirtei
This map shows the geographic impact of Elisa Tirtei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Tirtei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Tirtei more than expected).
Fields of papers citing papers by Elisa Tirtei
This network shows the impact of papers produced by Elisa Tirtei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Tirtei. The network helps show where Elisa Tirtei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisa Tirtei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 0 | |
| 9 | 2021 | 0 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 5 | |
| 13 | 2019 | 3 | |
| 14 | 2019 | 19 | |
| 15 | 2019 | 14 | |
| 16 | 2018 | 2 | |
| 17 | 2017 | 27 | |
| 18 | 2017 | 8 | |
| 19 | 2016 | 8 | |
| 20 | 2014 | 16 |
About Elisa Tirtei
Elisa Tirtei is a scholar working on Rheumatology, Neurology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 190 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (12 papers), Neuroblastoma Research and Treatments (6 papers), Bone Tumor Diagnosis and Treatments (5 papers), Cancer Genomics and Diagnostics (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Genetic Syndromes and Imprinting (2 papers), Acute Myeloid Leukemia Research (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Neurology (42 citations), Cancer Research (36 citations) and Oncology (57 citations). Elisa Tirtei has collaborated with scholars based in Italy, Denmark and United Kingdom. Frequent co-authors include Franca Fagioli, Sebastian Dorin Asaftei, Matteo Cereda, Anna Paioli, Marilena Cesari, M. Rocca, Nicoletta Bertorello, Eleonora Biasin, Giulia Zucchetti and Stefano Ferrari. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.